© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
This series follows one patient’s journey with multiple myeloma through diagnosis and treatment information, provided by Elie Fahed, MD.
April 14th 2021
Elie Fahed, MD, provides an overview of what multiple myeloma is, and Beth walks us through her frustrating journey to initial diagnosis as an atypical patient.
Beth goes into the challenges she faced regarding multiple myeloma diagnosis due to her atypical case and discusses the first treatments that she received.
Elie Fahed, MD, describes the process and rationale for autologous stem cell transplant in multiple myeloma, and Beth shares her experience with receiving one.
Beth provides insight into her mindset at initial multiple myeloma diagnosis, after autologous stem cell transplant, while in remission, and at first relapse.
April 15th 2021
Beth describes the first relapse of multiple myeloma she experienced, and Elie Fahed, MD, explains what free light chains are and the role that they play.
Beth compares her experiences with two multiple myeloma chemotherapy regimens, and Mark shares thoughts on Beth’s remission.
Beth discusses the impact on quality of life caused by her second relapse of multiple myeloma, as well as shares her experience with subsequent treatment.
Elie Fahed, MD, and Beth have an in-depth discussion on the physical and mental side effects Beth experiences while being treated for multiple myeloma.
April 22nd 2021
Mark provides insight into multiple myeloma from the perspective of the caregiver and offers advice to others who might be in the same position.
Dr. Elie Fahed explains Beth’s diagnosis of triple-class refractory multiple myeloma and targeted therapy, and Beth recalls symptoms and side effects she experienced.
Healthy Habits May Offset Genetic Cancer Risk
Expert Explains Prognosis Indicators, Treatment Plans in MCL
Smoking Cessation May Provide ‘Huge Benefit’ After Lung Cancer Diagnosis
The Game of Cancer